Skip to main content
NCBI home page
Gut logoLink to Gut
. 1980 Mar;21(3):219–222. doi: 10.1136/gut.21.3.219

Are serum bile salt concentrations raised in hyperlipidaemia?

G J Beckett, J G Douglas, N D Finlayson, I W Percy-Robb
PMCID: PMC1420344  PMID: 7399323

Abstract

We have studied serum fasting and postprandial primary bile salt concentrations in a group of 10 consecutive hyperlipidaemic subjects. The efficiency of hepatic bile salt clearance in the same subjects was aslo studied using an injected dose of sodium glycocholate. No increase in serum fasting or postprandial concentrations of the primary bile salts were observed and hepatic bile salt clearance was only marginally abnormal in one subject. The presence of hyperlipidaemia does not invalidate the use of serum conjugated bile salt analysis for the detection of liver diseases.

Full text

PDF
219

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beckett G. J., Corrie J. E., Percy-Robb I. W. The preparation of 125I-labelled bile acid ligands for use in the radioimmunoassay of bile acids. Clin Chim Acta. 1979 Apr 2;93(1):145–150. doi: 10.1016/0009-8981(79)90255-9. [DOI] [PubMed] [Google Scholar]
  2. Beckett G. J., Douglas J. G., Nimmo I. A., Finlayson N. D., Percy-Robb I. W. The effect of age on the intravenous sodium glycocholate test. Clin Chim Acta. 1980 Jan 31;100(3):193–200. doi: 10.1016/0009-8981(80)90266-1. [DOI] [PubMed] [Google Scholar]
  3. Beckett G. J., Hunter W. M., Percy-Robb I. W. Investigations into the choice of immunogen, ligand, antiserum and assay conditions for the radioimmunoassay of conjugated cholic acid. Clin Chim Acta. 1978 Sep 1;88(2):257–266. doi: 10.1016/0009-8981(78)90430-8. [DOI] [PubMed] [Google Scholar]
  4. Kaplowitz N., Kok E., Javitt N. B. Postprandial serum bile acid for the detection of hepatobiliary disease. JAMA. 1973 Jul 16;225(3):292–293. [PubMed] [Google Scholar]
  5. LaRusso N. F., Hoffman N. E., Hofmann A. F., Korman M. G. Validity and sensitivity of an intravenous bile acid tolerance test in patients with liver disease. N Engl J Med. 1975 Jun 5;292(23):1209–1214. doi: 10.1056/NEJM197506052922303. [DOI] [PubMed] [Google Scholar]
  6. Lewis B., Tabaqchali S., Panveliwalla D., Wootton I. D. Serum-bile-acids in the stagnant-loop syndrome. Lancet. 1969 Feb 1;1(7588):219–220. doi: 10.1016/s0140-6736(69)91238-0. [DOI] [PubMed] [Google Scholar]
  7. Pennington C. R., Ross P. E., Bateson M. C., Bouchier I. A. Serum bile acids in patients with hyperlipidaemia. J Clin Pathol. 1978 Jan;31(1):58–62. doi: 10.1136/jcp.31.1.58. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Pennington C. R., Ross P. E., Bouchier I. A. Serum bile acids in the diagnosis of hepatobiliary disease. Gut. 1977 Nov;18(11):903–908. doi: 10.1136/gut.18.11.903. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Thompson E. N., Williams R. Effect of age on liver function with particular reference to bromsulphalein excretion. Gut. 1965 Jun;6(3):266–269. doi: 10.1136/gut.6.3.266. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES